These observations suggested a stimulatory role for Gal-9 in COVID-19 patients, possibly by enhancing innate immune cell activation (e.g., monocytes/macrophages, neutrophils, and NK cells) and induction of proinflammatory cytokines/chemokines. Here, LGALS9 is linked to COVID-19.